BR0015124A - Método de preparação de um enanciÈmero substancialmente puro - Google Patents

Método de preparação de um enanciÈmero substancialmente puro

Info

Publication number
BR0015124A
BR0015124A BR0015124-6A BR0015124A BR0015124A BR 0015124 A BR0015124 A BR 0015124A BR 0015124 A BR0015124 A BR 0015124A BR 0015124 A BR0015124 A BR 0015124A
Authority
BR
Brazil
Prior art keywords
alkyl
carbon atoms
substantially pure
carbons
preparing
Prior art date
Application number
BR0015124-6A
Other languages
English (en)
Portuguese (pt)
Inventor
Nnochiri N Ekwuribe
Kenneth D James
Original Assignee
Nobex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nobex Corp filed Critical Nobex Corp
Publication of BR0015124A publication Critical patent/BR0015124A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00—Preparation of sulfones; Preparation of sulfoxides
    • C07C315/06—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00—Preparation of sulfones; Preparation of sulfoxides
    • C07C315/04—Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/26—Separation; Purification; Stabilisation; Use of additives
    • C07C319/28—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR0015124-6A 1999-10-27 2000-10-25 Método de preparação de um enanciÈmero substancialmente puro BR0015124A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16188499P 1999-10-27 1999-10-27
PCT/US2000/041609 WO2001034563A1 (en) 1999-10-27 2000-10-25 Resolution of intermediates in the synthesis of substantially pure bicalutamide

Publications (1)

Publication Number Publication Date
BR0015124A true BR0015124A (pt) 2002-07-02

Family

ID=22583193

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0015124-6A BR0015124A (pt) 1999-10-27 2000-10-25 Método de preparação de um enanciÈmero substancialmente puro

Country Status (19)

Country Link
US (1) US6593492B1 (https=)
EP (1) EP1224167A1 (https=)
JP (1) JP4778178B2 (https=)
KR (1) KR20020067509A (https=)
CN (1) CN1413188A (https=)
AU (1) AU2619501A (https=)
BR (1) BR0015124A (https=)
CA (1) CA2389100A1 (https=)
CZ (1) CZ20021434A3 (https=)
HK (1) HK1048299A1 (https=)
HU (1) HUP0203186A2 (https=)
IL (2) IL149256A0 (https=)
MX (1) MXPA02004225A (https=)
NO (1) NO20021999L (https=)
NZ (1) NZ518552A (https=)
PL (1) PL360059A1 (https=)
TW (1) TWI271397B (https=)
WO (1) WO2001034563A1 (https=)
ZA (1) ZA200203228B (https=)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6995284B2 (en) 2000-08-24 2006-02-07 The University Of Tennessee Research Foundation Synthesis of selective androgen receptor modulators
US6071957A (en) 1996-11-27 2000-06-06 The University Of Tennessee Research Corporation Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
US6838484B2 (en) 2000-08-24 2005-01-04 University Of Tennessee Research Foundation Formulations comprising selective androgen receptor modulators
US7622503B2 (en) 2000-08-24 2009-11-24 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US8008348B2 (en) 2001-12-06 2011-08-30 University Of Tennessee Research Foundation Treating muscle wasting with selective androgen receptor modulators
US7026500B2 (en) 2000-08-24 2006-04-11 University Of Tennessee Research Foundation Halogenated selective androgen receptor modulators and methods of use thereof
US6998500B2 (en) 2000-08-24 2006-02-14 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US8445534B2 (en) 2000-08-24 2013-05-21 University Of Tennessee Research Foundation Treating androgen decline in aging male (ADAM)-associated conditions with SARMs
EP1406855A4 (en) * 2001-06-13 2006-04-19 Teva Gyogyszergyar Reszvenytar NOVEL PROCESS FOR THE PREPARATION OF RAC-BICALUTAMIDE AND INTERMEDIATE PRODUCTS THEREOF
US8853266B2 (en) 2001-12-06 2014-10-07 University Of Tennessee Research Foundation Selective androgen receptor modulators for treating diabetes
DK1463497T3 (da) 2001-12-06 2012-01-30 Gtx Inc Behandling af muskelsvind med selektive androgenreceptormodulatorer
NZ533943A (en) * 2001-12-13 2006-06-30 Sumitomo Chemical Co Crystal of bicalutamide and production method thereof
CA2475108A1 (en) 2002-02-07 2003-08-14 Mitchell S. Steiner Treating benign prostate hyperplasia with sarms
AU2003217304A1 (en) 2002-02-28 2003-09-16 The University Of Tennessee Research Corporation Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy
US7803970B2 (en) 2002-02-28 2010-09-28 University Of Tennessee Research Foundation Multi-substitued selective androgen receptor modulators and methods of use thereof
US7705182B2 (en) 2002-02-28 2010-04-27 University Of Tennessee Research Foundation Multi-substituted selective androgen receptor modulators and methods of use thereof
US7772433B2 (en) 2002-02-28 2010-08-10 University Of Tennessee Research Foundation SARMS and method of use thereof
US7741371B2 (en) 2002-06-17 2010-06-22 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
JP2005529952A (ja) 2002-06-17 2005-10-06 ユニバーシティ・オブ・テネシー・リサーチ・ファウンデーション Ｎ架橋選択的アンドロゲン受容体修飾物質及びその使用方法
US6818766B2 (en) 2002-10-02 2004-11-16 Synthon Bv Process for making bicalutamide and intermediates thereof
US8309603B2 (en) 2004-06-07 2012-11-13 University Of Tennessee Research Foundation SARMs and method of use thereof
US9884038B2 (en) 2004-06-07 2018-02-06 University Of Tennessee Research Foundation Selective androgen receptor modulator and methods of use thereof
US9889110B2 (en) 2004-06-07 2018-02-13 University Of Tennessee Research Foundation Selective androgen receptor modulator for treating hormone-related conditions
EP1669347A1 (en) * 2004-12-10 2006-06-14 Helm AG Process for the preparation of 3-¬(4-fluorophenyl) sulfonyl|-2-hydroxy-2-methyl propionic acid
US20060269596A1 (en) * 2005-01-12 2006-11-30 Gary Liversidge Controlled release compositions comprising an acylanilide
KR20070114343A (ko) * 2005-03-29 2007-12-03 유에스브이 리미티드 비칼루타미드의 제조 방법
US7550505B2 (en) * 2006-07-24 2009-06-23 University Of Delaware Pan-antagonists for the androgen receptor and androgen receptor mutants associated with anti-androgen withdrawal
US9844528B2 (en) 2006-08-24 2017-12-19 University Of Tennessee Research Foundation SARMs and method of use thereof
ES2581765T3 (es) 2006-08-24 2016-09-07 University Of Tennessee Research Foundation Acilanilidas sustituidas y métodos de uso de las mismas
US10010521B2 (en) 2006-08-24 2018-07-03 University Of Tennessee Research Foundation SARMs and method of use thereof
US9730908B2 (en) 2006-08-24 2017-08-15 University Of Tennessee Research Foundation SARMs and method of use thereof
US7968603B2 (en) 2007-09-11 2011-06-28 University Of Tennessee Research Foundation Solid forms of selective androgen receptor modulators
US8450374B2 (en) * 2009-06-29 2013-05-28 University Of Delaware Pan-antagonists for the androgen receptor and androgen receptor mutants associated with anti-androgen withdrawal
WO2012042532A1 (en) 2010-09-29 2012-04-05 Shilpa Medicare Limited Process for preparing bicalutamide
CN103539710A (zh) * 2012-07-02 2014-01-29 国药一心制药有限公司 一种（r）-比卡鲁胺的合成方法
LT2872482T (lt) 2012-07-13 2020-12-28 Oncternal Therapeutics, Inc. Krūties vėžių gydymo būdas selektyviu androgeno receptoriaus moduliatoriumi
US10987334B2 (en) 2012-07-13 2021-04-27 University Of Tennessee Research Foundation Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs)
US9622992B2 (en) 2012-07-13 2017-04-18 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US9744149B2 (en) 2012-07-13 2017-08-29 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US10258596B2 (en) 2012-07-13 2019-04-16 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US9969683B2 (en) 2012-07-13 2018-05-15 Gtx, Inc. Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS)
US10314807B2 (en) 2012-07-13 2019-06-11 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
CN104897818A (zh) * 2015-06-19 2015-09-09 重庆医药高等专科学校 一种同时测定比卡鲁胺中6种有关物质的uplc方法
CN108069887B (zh) * 2016-11-17 2021-04-20 山西振东制药股份有限公司 一种(r)-比卡鲁胺中间体的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58183669A (ja) * 1982-04-19 1983-10-26 Teikoku Chem Ind Corp Ltd 光学活性なプロピオン酸誘導体の製造方法
ATE28864T1 (de) * 1982-07-23 1987-08-15 Ici Plc Amide-derivate.
GB8617652D0 (en) * 1986-07-18 1986-08-28 Ici Plc Acylanilide derivatives
PL308473A1 (en) * 1992-10-21 1995-08-07 Pfizer Enabntiomeric cis-3-(4,6-dihydoxychroman-3-yl methyl)bezoic acids
AU1687395A (en) 1994-01-21 1995-08-08 Sepracor, Inc. Methods and compositions for treating androgen-dependent diseases using optically pure r-(-)-casodex
WO1998055153A1 (en) 1997-06-04 1998-12-10 The University Of Tennessee Research Corporation Non-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imaging

Also Published As

Publication number Publication date
WO2001034563A1 (en) 2001-05-17
PL360059A1 (en) 2004-09-06
IL149256A (en) 2011-05-31
HUP0203186A2 (hu) 2003-01-28
NO20021999D0 (no) 2002-04-26
CZ20021434A3 (cs) 2002-11-13
AU2619501A (en) 2001-06-06
KR20020067509A (ko) 2002-08-22
ZA200203228B (en) 2003-07-23
JP2003513955A (ja) 2003-04-15
CN1413188A (zh) 2003-04-23
TWI271397B (en) 2007-01-21
NO20021999L (no) 2002-06-20
IL149256A0 (en) 2002-11-10
HK1048299A1 (zh) 2003-03-28
JP4778178B2 (ja) 2011-09-21
MXPA02004225A (es) 2002-10-17
NZ518552A (en) 2003-10-31
EP1224167A1 (en) 2002-07-24
US6593492B1 (en) 2003-07-15
CA2389100A1 (en) 2001-05-17

Similar Documents

Publication Publication Date Title
BR0015124A (pt) Método de preparação de um enanciÈmero substancialmente puro
BR0014889A (pt) Métodos para assimetricamente sintetizar um enanciÈmero de uma acilanilida ou um seu derivado, para tratar câncer de próstata, para formar um composto opticamente ativo e para sintetizar um composto opticamente ativo, e, composto
ES2154398T3 (es) Piridinas 2,3-sustituidas para el tratamiento de la inflamacion.
CO4990955A1 (es) Derivados de n-alcanoilofenilalanina
BG103980A (en) 4-phenylpiperidine compounds
NO20002361L (no) Kjemiske forbindelser
CO5540341A2 (es) Arilaminas para el tratamiento de condiciones asociadas con gsk-3
BR9813989A (pt) Composto, processo para prepará-lo, uso do mesmo, composição farmacêutica, e, processo para o tratamento de um paciente sofrendo de uma condição
NO20002360L (no) Kjemiske forbindelser
DK0887344T3 (da) Quinoliner og quinazoliner, som er nyttige ved terapi
NZ296524A (en) 2,2-Dichloroalkane carboxylic acids, preparation and pharmaceutical compositions
NO961085L (no) Androsteroner
DK1447400T3 (da) Bicyklisk forbindelse
FI864618A0 (fi) Nya 3-oxadiazol- och 3-karboksylsyra- -karbolinderivat, deras framstaellning och deras anvaendning som laekemedel.
ES479217A1 (es) Un procedimiento para la preparacion de derivados de dibenzo b, f tiepinas.
ES2188134T3 (es) Derivados de ciclohexandiol.
DK0480155T3 (da) 4-Substituerede dihydropyrido(4,3-d)pyrimidiner som analgetica og topiske antiinflammatoriske midler til behandling af hudlidelser
SE8008555L (sv) Tioetylamidderivat
ES8701167A1 (es) Un procedimiento para preparar una quinolona
CO5650231A2 (es) Derivados de 1-(alquilaminoalquil-pirrolidin-/piperidinil)-2,2-difenilacetamida como antagonistas del receptor muscarinico, su procedimiento de sintesis y composiciones farmaceuticas que los contienen
ES2190222T3 (es) Derivados de 3-(2-oxo-(1,3')bipirrolindinil-3-iliden-metil)-cefem.
ATE195929T1 (de) Fluorierte alkane und ihre verwendungen
ES2035919T3 (es) Composiciones fungicidas.
DK27882A (da) Fremgangsmaade til fremstilling af n-substituerede polyglycidyl-urazolforbindelser
DK1417265T3 (da) Flydende farvesammensætninger med acyglyceroler som dispergeringsmidler

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]